# Pilot Study of Intermittent Fasting With Immune Checkpoint Inhibitors

> **NCT07645742** · NA · NOT_YET_RECRUITING · sponsor: **West Virginia University** · enrollment: 90 (estimated)

## Conditions studied

- Cancer (Advanced Stage)

## Interventions

- **BEHAVIORAL:** Alternate-Day Fasting (ADF)
- **BEHAVIORAL:** Time-Restricted Eating (TRE)

## Key facts

- **NCT ID:** NCT07645742
- **Lead sponsor:** West Virginia University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2029-02
- **Final completion:** 2029-02
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07645742

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07645742, "Pilot Study of Intermittent Fasting With Immune Checkpoint Inhibitors". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07645742. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
